PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Trends Analyst Outlook Journalist POV

19 hedge funds and large institutions have $14.1M invested in Protalix BioTherapeutics in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

36.07% more ownership

Funds ownership: 4.36% → 40.43% (+36%)

27% more funds holding

Funds holding: 15 → 19 (+4)

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$123K
Puts
$6K
Net Calls
Net Calls Change

Top Buyers

1
+$11.3M
2
+$955K
3
+$210K
4
Jane Street
Jane Street
New York
+$43.2K
5
Renaissance Technologies
Renaissance Technologies
New York
+$41.8K

Top Sellers

1
-$31.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$11.3M
2
$1.12M
3
$955K
4
$210K
5
$157K
6
$124K
7
$90K
8
$53K
9
$14K
10
$14K
11
$12K
12
$2.58K
13
$1K
14
$1K